Aidaptus is a two-step, spring-powered, single use auto-injector with a design that accommodates both 1mL and 2.25 mL prefilled glass syringes in the same base device. It also features stopper sensing technology with a self-adjusting plunger that automatically adapts to the individual stopper positions and different fill volumes in each syringe, with no change parts required. The auto-injector is available with two different spring strengths to accommodate a variety of drug viscosities.

Aidaptus has a patient-centric design with automatic needle insertion that provides a simple and consistent user experience. The stopper sensing technology, coupled with the independent, two-phase needle insertion and drug delivery, reduces any impact forces on the syringe, mitigating the risk of syringe breakages during use. With a needle that is shielded before, during and after use, Aidaptus provides reassurance to users who are new to auto-injectors as well as those who experience needle phobia. It can also give users confidence that the injection has been successfully completed with an audible notification at the start and end of the procedure. In addition, a bright yellow plunger rod is visible though a large window in the device confirming the end of injection.

Aidaptus is available in two base platform options: a clear outer body with colour overwrap permitting rapid selection of window size or traditional opaque housing, offering versatility for both branding and customisation as well as options for market segmentation and life cycle management. Its highly compact nature reflects the excellence in sustainable design and human factors engineering used throughout its development; coupled with consideration for ease of final assembly through application of design for manufacture (DfM) principles.

Michael Earl, director, Owen Mumford Pharmaceutical Services, said: “Our Aidaptus auto-injector platform has been designed to facilitate the growing market for subcutaneous injections used to treat a variety of chronic diseases like rheumatoid arthritis, Crohns’ disease and multiple sclerosis. With the increasing move towards treatment outside of the acute care setting, Aidaptus will help patients to self-administer their individual therapies using a simple and easy to use device. At the same time, this auto-injector can help to reduce complexity and risk in supply chain and final assembly for pharmaceutical and biotechnology companies’ combination products thanks to its ability to adapt to different syringe sizes and fill volumes. It is often the case that during development or life-cycle management of injectable drug products, changes in these parameters can occur. Now the device does not have to be changed as well.”

Aidaptus has been designed to meet the challenges of changes to drug formulation or injected volume and can therefore help reduce risk during drug development and lifecycle management.

The new product, known as the GB32U9, is SML's smallest inlay to date, according to the report in RFID Journal and is engineered to transmit data effectively when applied to vials filled with liquid and made from plastic or glass packaging. 

The Group is currently in the process of delivering the new inlays to at least one pharmaceutical company, but the RFID technology provider is also in discussions with other US-based businesses. The company began building RFID tag products for the pharmaceutical industry three years ago, according toDean Frew, SML Group's chief technology officer and senior VP of RFID solutions. However, he adds, widespread interest in the technology's use for drugs and other controlled substances at hospitals didn't see dramatic growth until 2019 and 2020.

"Just like with every other vertical," states Frew, "companies [in the pharmaceutical industry] are seeing what can be done with item-level RFID, and that leads to growing demand," both for the tags and for solutions that utilize the tag-read data to improve operations.Another accelerator to that growth is the advent of a new standard for pharmaceutical RFID tags, created by the DoseID consortium(newsletter 14/10/2020.) The GB32U9is among the first inlays to gain Spec S certification from the program.

The GB32U9, inlay isspecifically designed for unit-of-use medications in pharmaceutical applications, leverages  NXP's latest chip, the UCODE 9. According to Frew, the inlay provides high quality and rapid inventory countingin dense RFID tag populations.The challenge, he says, was to design a tag that would not detune when attached to a liquid-filled product. The company created an antenna that responds reliably in the presence of liquids, as well as a variety of other materials, including plastics or glass. The antenna must also work despite its very small size.The inlay's small design means it fits on a wide range of pharmaceutical products.

The GB32U9 was designed with auto-adjust technology, unique brand identifiers and a pre-serialized 96-bit Electronic Product Code (EPC). Its antenna measures 20mm by 10mm with a wet paper face size of 26mm by 12mm.Typically, the tags will be applied at the fill line by a pharmaceutical company, after which they can be read throughout the supply chain. 

The small size and material challenges mean the read range is shorter than standard UHF RFID tags, with a range of about 1m, but that varies depending on the environment and the type of reader being used. However for most drug products this is not a major issue, says Frew.The inlay is available now, following approximately 18 months of engineering and testing.

TimerCap’s Prescription Misuse Prevention Kits are the perfect tool to assists in preventing medication abuse and mistakes. Its patented stopwatch design makes it the most intuative and simplest way to protect your families and home. Track the time a pill bottle was last opened, down to the minute! It is as easy as closing the cap to start the timer and opening the cap to stop the timer. There are no alarms or programs to set, yes it is that simple! Families and communities can now have peace of mind in knowing how easy it can be to stay on top of taking your medications as prescribe, to detect unexpected openings and to deter others from experimenting.

TimerCap’s intuitive and simple patented stopwatch allows you to track every time a pill bottle is opened down to the second. This is to ensure that you’re taking your medication at the right time. This feature also helps with detecting/deterring unwanted openings. 

TimerCap’s do not include an alarm function. Our caps allow you to track when the last time the bottle was opened. TimerCap will track when the last time your prescription bottle was opened. This will help you keep track of your last dosage to avoid any medication mistakes. 

Color coded for Easy :Identifi cation Easily identify your medication by color for your convience.

It’s a Stopwatch : It is not a clock, so no alarms, no programs to set! The patented pressure switch automaticaly starts when the stopwatch cap is closed and stops when cap is opened.

Fits a Large Range : With the very popular 38-400 threaded bottle, these easy and simple caps will fi t most large, pharmacy and vitamin bottles.

Know, Don’t Guess! : Never forget when you last took your medication. The automatic stopwatch feature counts up for you.

Safety First :TimerCap ships EZ-Twist, and it’s great for seniors. It also contains a caution warning on each side in both English and Spanish.

Child Resistant Ring :TimerCap comes with a child resistant ring (CRC) that snaps on to protect your children.

Detect and Deter: Due to 52% of misuse starting at home, it is vital to have a tool that can detect, deter, and prevent theft or openings by seeing the time it was last opened.